Abstract
The extent of rare side effects of mRNA vaccines for coronavirus disease 2019 (COVID-19) remains unclear. Several cases of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) following COVID-19 vaccination have been reported. We herein report a 72-year-old man who presented with a fever after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. He was diagnosed with acute kidney injury due to myeloperoxidase-ANCA-associated vasculitis and was treated with intermittent hemodialysis, high-dose prednisolone, and intravenous rituximab. His general symptoms and renal impairment subsequently improved. When systemic symptoms are prolonged or renal abnormalities appear after COVID-19 vaccination, the possibility of AAV should be considered.
Keywords: ANCA-associated vasculitis; COVID-19 vaccine; rapidly progressive glomerulonephritis.
【저자키워드】 COVID-19 vaccine, ANCA-associated vasculitis, rapidly progressive glomerulonephritis., 【초록키워드】 COVID-19, coronavirus disease, antibody, mRNA vaccine, Acute kidney injury, Symptom, Hemodialysis, COVID-19 vaccination, Fever, Vasculitis, Pfizer-BioNTech, Prednisolone, intravenous, High-dose, Side effect, second dose, renal impairment, reported, diagnosed, receiving, treated, cytoplasmic, renal abnormality, systemic symptom, 【제목키워드】 COVID-19, Pfizer-BioNTech,